[Cyclic adenosine monophosphate and prostaglandins in oncology].
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002477:Cells / Q000201:enzymology; D002478:Cells, Cultured; D002625:Chemistry, Organic; D006224:Cricetinae; D000242:Cyclic AMP / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D004794:Enzyme Repression / Q000187:drug effects; D005260:Female; D006801:Humans; D051379:Mice; D008968:Molecular Conformation; D009369:Neoplasms / Q000201:enzymology / Q000503:physiopathology*; D009374:Neoplasms, Experimental / Q000201:enzymology; D055601:Organic Chemistry Phenomena; D010053:Ovary / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D013329:Structure-Activity Relationship
D011453:Prostaglandins; D000242:Cyclic AMP
Tsiklicheskiĭ adenozinmonofosfat i prostaglandiny v onkologii